These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


760 related items for PubMed ID: 19117937

  • 1. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D, Lanzetta P, Perissin L, Bandello F.
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
    Bonini-Filho MA, Jorge R, Barbosa JC, Calucci D, Cardillo JA, Costa RA.
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
    [Abstract] [Full Text] [Related]

  • 3. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA, Melo LA, Costa RA, Skaf M, Belfort R, Souza-Filho AA, Farah ME, Kuppermann BD.
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [Abstract] [Full Text] [Related]

  • 4. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S, Bahçeci UA, Gürelik G, Hasanreisoğlu B.
    J Diabetes Complications; 2006 Sep; 20(4):246-51. PubMed ID: 16798476
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A.
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
    Grenga P, Lupo S, Domanico D, Vingolo EM.
    Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema.
    Takata C, Messias A, Folgosa MS, Lucena LR, Lucena DR, Scott IU, Jorge R.
    Retina; 2010 Apr; 30(4):562-9. PubMed ID: 20182403
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S.
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP.
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M.
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H, Habot-Wilner Z, Alhalel A, Moroz I, Glovinsky J, Moisseiev J.
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
    Margolis R, Singh RP, Bhatnagar P, Kaiser PK.
    Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.